Form 4 for RH RH
Accepted 2026-04-01 20:00:07 ET · period of report 2026-03-31 · accession 0001560810-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-01 20:00 | 2026-03-31 | RH | Chaya Eri | SEE REMARKS, Dir | M - OptEx | $39.42 | +11.0K | 11.0K | New | +$433.6K |
| DM | 2026-04-01 20:00 | 2026-03-31 | RH | Chaya Eri | SEE REMARKS, Dir | S - Sale+OE | $137.92 | -11.0K | 0 | -100% | -$1.52M |
| D | 2026-04-01 20:00 | 2026-03-31 | RH | Chaya Eri | SEE REMARKS, Dir | M - OptEx | $0.00 | -11.0K | 25.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | M | A | 11,000 | $39.42 | 11,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-31 | S | D | 1,100 | $135.27 | 9,900 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F2) This transaction was executed in multiple trades ranging from $134.58 to $135.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 3 | Common | Common Stock | 2026-03-31 | S | D | 2,000 | $135.93 | 7,900 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F3) This transaction was executed in multiple trades ranging from $135.58 to $136.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 4 | Common | Common Stock | 2026-03-31 | S | D | 1,600 | $137.04 | 6,300 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F4) This transaction was executed in multiple trades ranging from $136.65 to $137.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2026-03-31 | S | D | 1,678 | $138.21 | 4,622 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F5) This transaction was executed in multiple trades ranging from $137.72 to $138.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 6 | Common | Common Stock | 2026-03-31 | S | D | 2,922 | $139.38 | 1,700 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F6) This transaction was executed in multiple trades ranging from $138.75 to $139.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 7 | Common | Common Stock | 2026-03-31 | S | D | 1,700 | $140.02 | 0 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F7) This transaction was executed in multiple trades ranging from $139.75 to $140.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-03-31 | M | D | 11,000 | $0.00 | 25,000 | D | $39.42 · — to 2026-05-03 | 11,000 Common Stock | (F9) This option award is fully vested and exercisable. |